Related Experiment Video
Updated: May 1, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text
1Medical Informatics Division, Case Western Reserve University, Cleveland, OH, USA. rxx@case.edu.
This study introduces a novel computational approach to build a large-scale disease-disease risk relationship knowledge base (dRiskKB) from biomedical literature. The dRiskKB aids in understanding disease etiology and discovering new drug repositioning opportunities.
Area of Science:
- Computational biology
- Bioinformatics
- Medical informatics
Background:
- Discerning genetic contributions to complex diseases requires advanced computational methods.
- Systems approaches to disease relationships are crucial for gene discovery and drug repositioning.
- Lack of large-scale, machine-understandable disease relationship knowledge bases limits phenome-wide studies.
Purpose of the Study:
- To develop a precise, large-scale disease-disease risk relationship knowledge base (dRiskKB).
- To leverage a semi-supervised iterative pattern learning approach for knowledge base construction.
- To facilitate disease etiology research and drug repositioning.
Main Methods:
- Utilized 21,354,075 MEDLINE records.
- Employed a semi-supervised iterative pattern learning approach starting with a seed pattern.
- Extracted disease risk pairs (D1 → D2) and manually evaluated precision.
- Analyzed correlations between disease risk pairs, genes, and drugs.
Main Results:
- Constructed dRiskKB with 34,448 unique D1 → D2 risk pairs among 12,981 diseases.
- Achieved high precision for learned patterns (0.99) and extracted pairs (0.919-0.988).
- Demonstrated algorithm robustness and identified shared genes and drugs for diseases with similar risk profiles.
Conclusions:
- The dRiskKB offers a valuable resource for understanding disease etiology.
- Integration with other datasets can enhance disease understanding and drug repositioning efforts.
- The developed computational approach is effective for building large-scale biomedical knowledge bases.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Statistical Software for Data Analysis and Clinical Trials
Principles of Disease Surveillance
Infectious Diseases and Their Occurrence
Drug Dosing: Obese Patients

